文献速递泌尿生殖腹部MR

磁共振成像检测增大的犬前列腺中葡萄糖刺激的锌分泌,作为鉴别前列腺癌与良性前列腺增生的潜在方法

Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
PubMed 文献 · Invest Radiol · 2021-01-01

本研究在4只临床诊断为良性前列腺增生的老年完整雄性犬中,于3 T扫描仪上比较静脉注射GdL1联合葡萄糖与联合生理盐水后的磁共振信号变化。结果显示葡萄糖组前列腺组织对比噪声比高于生理盐水组,组织学证实为良性前列腺增生;1只犬检出前列腺上皮内瘤变,该区域葡萄糖刺激的锌分泌较低,提示该方法可能有助于鉴别前列腺癌与良性前列腺增生。

要点

  • 静脉注射GdL1联合葡萄糖后,犬良性前列腺增生组织T1加权MRI对比噪声比高于联合生理盐水,符合葡萄糖刺激的锌分泌。
  • 1只犬组织学检出前列腺上皮内瘤变,该区域葡萄糖刺激的锌分泌较低,T2加权扫描同区域见可疑肿块。
  • 作者认为该技术可能为MRI检测前列腺癌、鉴别移行区良性前列腺增生与前列腺癌提供新方法。

核心结论

  • 增大的犬前列腺T1加权MRI显示,注射GdL1加葡萄糖后的r-CNR高于GdL1加生理盐水,符合良性前列腺增生组织的葡萄糖刺激的锌分泌;单只犬的一个小区域肿瘤组织显示葡萄糖刺激的锌分泌较低,作者认为这提示一种可能有助于鉴别移行区良性前列腺增生与前列腺癌的MRI新方法。

研究设计与样本

  • 研究论文;4只6岁或以上、前列腺增大的完整雄性犬,临床诊断为良性前列腺增生;使用3 T扫描仪,序列为T1加权涡轮自旋回波(TE/TR 12/400毫秒)和T2加权(TE/TR 112/5000毫秒);每只犬间隔一周进行两次成像,随机决定顺序,分别静脉注射0.05 mmol/kg GdL1加2 mL/kg 50%葡萄糖或加2 mL/kg生理盐水;第二次成像后安乐死并取前列腺行组织病理学检查;基线和干预后血浆及尿液样本用感应耦合等离子体质谱法分析总锌。

关键影像表现/征象

  • 注射后13分钟,葡萄糖成像会话的平均±标准差r-CNR为134%±10%,生理盐水成像会话为127%±7%(P<0.01);组织病理学证实所有犬均为良性前列腺增生,1只动物检出前列腺上皮内瘤变,T2加权扫描同区域见可疑肿块;该肿块在葡萄糖组和生理盐水组的r-CNR分别为113%±4%和111%±6%,两种干预间无显著差异(P=0.54);全前列腺r-CNR在葡萄糖干预为130%±11%,生理盐水干预为125%±9%,差异有统计学意义(P=0.03)。

诊断标准与关键数值

  • 以注射后任一时间点CNR与基线CNR的比值定义为r-CNR;注射后13分钟葡萄糖成像会话r-CNR为134%±10%,生理盐水成像会话为127%±7%(P<0.01);前列腺上皮内瘤变肿块r-CNR在葡萄糖组为113%±4%、生理盐水组为111%±6%(P=0.54);全前列腺r-CNR葡萄糖组130%±11% vs 生理盐水组125%±9%(P=0.03)。

临床应用与阅片要点

  • 作者认为这些发现提示一种通过MRI检测前列腺癌的新方法,可能有助于鉴别移行区良性前列腺增生与前列腺癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: In the United States, prostate cancer (PCa) is the most common cancer in men. Multi-parametric magnetic resonance imaging (MRI) is increasingly being relied upon for the diagnosis and characterization of PCa, but differentiating malignancy from benign prostatic hyperplasia (BPH) in the transition zone using MRI can be challenging. The characteristically high levels of zinc in human prostate tissue and a close relationship between malignant proliferation and zinc homeostatic dysregulation create opportunities to visualize PCa with novel contrast media. In mouse models, glucose-stimulated zinc secretion (GSZS) can be preferentially observed in healthy prostate tissue compared with malignant tissue; in vivo, these differences can be captured with MRI by using Gdl1, a gadolinium-based zinc-responsive contrast agent. In this study, we examined whether this technology can be applied in a large animal model by imaging older dogs with clinically diagnosed BPH.

MATERIALS AND METHODS: Four intact male dogs 6 years or older with enlarged prostates were imaged (T1-weighted turbo spin-echo, TE/TR, 12/400 milliseconds and T2-weighted, TE/TR, 112/5000 milliseconds) using a 3 T scanner before and at multiple time points after intravenous injection of 0.05 mmol/kg GdL1 plus either (a) 2 mL/kg of 50% dextrose in 1 session or (b) 2 mL/kg normal saline in another session. The two sessions were one week apart, and their order was randomly determined for each dog. During postprocessing, regions of interest were generated in prostate tissue and in paraspinal muscles to evaluate the contrast-to-noise ratio (CNR). The ratio of CNR at any postinjection time point compared with baseline CNR was defined as r-CNR. After the second imaging session, the dogs were euthanized, and their prostates were harvested for histopathological examination. Baseline and postintervention plasma and urine samples were analyzed for total zinc by inductively coupled plasma mass spectrometry.

RESULTS: The mean ± SD r-CNR values at 13 minutes postinjection in the dextrose versus saline imaging sessions were 134% ± 10% and 127% ± 7%, respectively (P < 0.01). The histopathologic evaluation of prostate tissues confirmed BPH in all dogs. Interestingly, prostatic intraepithelial neoplasia was detected in 1 animal, and a suspicious mass was found in the same region on T2-weighted scans. The r-CNR of the mass was calculated as 113% ± 4% and 111% ± 6% in the dextrose and saline groups, respectively, with no significant differences between the 2 interventions (P = 0.54), whereas there was a statistically significant difference between the r-CNR of the whole prostate in the dextrose (130% ±11%) and saline (125% ± 9%) interventions (P = 0.03). Inductively coupled plasma mass spectrometry analyses showed a significantly higher urinary zinc in the dextrose versus saline groups, but no differences were found in plasma zinc levels.

CONCLUSIONS: T1-weighted MRI of the enlarged canine prostate showed higher r-CNR after injection of GdL1 plus dextrose compared with GdL1 plus saline, consistent with GSZS from BPH tissues. One small region of neoplastic tissue was identified in a single dog on the basis of less GSZS from that region by MRI. These findings suggest a new method for the detection of PCa by MRI that could facilitate the differentiation of BPH from PCa in the transition zone.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Khalighinejad P, Parrott D, Jordan VC, et al. Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia. Invest Radiol. 2021. PMID: 34086013. doi:10.1097/RLI.0000000000000760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。